A major new global analysis involving 42 countries, has found colon cancer is the only form of the disease to have solely ...
Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with ...
An international team of researchers has uncovered a promising new avenue for treating colorectal cancer, the world's third ...
Guardant Health is breaking barriers and hoping to get more people screened through the “Shield” test. In 2024, over 53,000 people died from colon cancer in ...
Exact Sciences is facing backlash for sending unsolicited Cologuard colon cancer screening kits to consumers, sparking ...
BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
Some on Wall Street weren’t too impressed with results from a pivotal trial that tested an Exelixis drug, zanzalintinib, in ...
After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal ...
WBAL-TV on MSN
You may not know CHEK2. Here's why you should
Katharine Bisordi, a genetic counselor at Mercy Medical Center in Baltimore, said not everyone with CHEK2 will have the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback